Ladenburg Thalmann Financial Services’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$5K	Buy	91 +7	+8%	+$371	﹤0.01%	4821
2019 Q3	$5K	Buy	84 +5	+6%	+$291	﹤0.01%	4729
2019 Q2	$5K	Sell	79 -4	-5%	-$252	﹤0.01%	4745
2019 Q1	$5K	Sell	83 -1	-1%	-$66	﹤0.01%	4704
2018 Q4	$5K	Buy	+84	New	+$5.02K	﹤0.01%	4639
2016 Q1	–	Sell	-4,402	Closed	-$189K	–	4866
2015 Q4	$189K	Buy	4,402 +2,630	+148%	+$132K	﹤0.01%	1622
2015 Q3	$77K	Buy	1,772 +1,770	+88,500%	+$95.5K	﹤0.01%	2181
2015 Q2	$0	Hold	2	–	–	﹤0.01%	4805
2015 Q1	$0	Hold	2	–	–	﹤0.01%	4696
2014 Q4	$0	Buy	+2	New	+$76	﹤0.01%	4480

Other funds holding BSTC

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ladenburg Thalmann Financial Services's BSTC Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its BioSpecifics Technologies Corp. (BSTC) stake by 8.3% in Q4 2019, buying an estimated $371 and bringing the position to 91 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #4821.

Ladenburg Thalmann Financial Services first reported a position in BSTC in Q4 2014 and has held it in 10 quarters since. The position peaked at $189K in Q4 2015. 112 funds tracked by Wall St. Rank hold BSTC as of Q4 2019.

Ladenburg Thalmann Financial Services held 91 shares of BioSpecifics Technologies Corp. worth $5K as of Q4 2019.
Ladenburg Thalmann Financial Services bought 7 BioSpecifics Technologies Corp. shares in Q4 2019, an estimated $371.
BioSpecifics Technologies Corp. made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4821 holding.
Ladenburg Thalmann Financial Services first reported a position in BioSpecifics Technologies Corp. in Q4 2014 and has held it in 10 quarters since.
Ladenburg Thalmann Financial Services's BioSpecifics Technologies Corp. position peaked at $189K in Q4 2015.
112 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.